See All Slides - tctmd.com

Slides

Presentation TCT 2015

Acute Complication Case Presentations 1: Dissections, Intramural Hematomas, and Perforations by IVUS (and Recommendations for Treatment)

Presenter: Carlo Di Mario, John McB. Hodgson, Akiko Maehara

October 11, 2015

Presentation TCT 2015

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? Yes, the Benefits Outweigh the Risks!

Presenter: John A. Bittl, E. Magnus Ohman, Christoph A. Kaiser

October 11, 2015

Presentation TCT 2015

Bioresorbable Scaffolds in STEMI: Rationale and 1-Year TROFI II Results

Presenter: Dariusz Dudek, Robert J. de Winter, Patrick W. Serruys

October 11, 2015

Presentation TCT 2015

Acute and Late Results After Surgical Repair and Replacement of Degenerative MR

Presenter: Michael J. Mack, Patrick M. McCarthy, James S. Gammie

October 11, 2015

Presentation TCT 2015

Bayesian Statistics: Can They Be Trusted (or Understood)?!

Presenter: Stuart J. Pocock, Jan Tijssen, Sanjay Kaul

October 11, 2015

Presentation TCT 2015

Preparing the Lab for CHIP (Including Disaster Planning)

Presenter: Martina Kelly Speight, Donna Dasinger

October 11, 2015

Presentation TCT 2015

Has the TASC Classification Scheme Been Made Obsolete by Todays Antiproliferative Therapeutics?

Presenter: Hans Krankenberg, Lindsay S. Machan

October 11, 2015

Presentation TCT 2015

Specialized Stents in STEMI: MGuard From MASTER I to MASTER II

Presenter: Dariusz Dudek, Robert J. de Winter, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

What Are the Major Steps (and Hurdles) to Becoming a CTO Operator?

Presenter: Etsuo Tsuchikane, Gerald S. Werner, James C. Spratt

October 11, 2015

Presentation TCT 2015

How Good Can Surgical Outcomes Be in Secondary MR? The Expert Surgeons Perspective

Presenter: Michael J. Mack, Patrick M. McCarthy

October 11, 2015

Advertisement

Slides

Acute Complication Case Presentations 1: Dissections, Intramural Hematomas, and Perforations by IVUS (and Recommendations for Treatment)

Debate: Should Prasugrel and Ticagrelor Be Used in a Substantial Number of Patients With Stable CAD? Yes, the Benefits Outweigh the Risks!

Bioresorbable Scaffolds in STEMI: Rationale and 1-Year TROFI II Results

Acute and Late Results After Surgical Repair and Replacement of Degenerative MR

Bayesian Statistics: Can They Be Trusted (or Understood)?!

Preparing the Lab for CHIP (Including Disaster Planning)

Has the TASC Classification Scheme Been Made Obsolete by Todays Antiproliferative Therapeutics?

Specialized Stents in STEMI: MGuard From MASTER I to MASTER II

What Are the Major Steps (and Hurdles) to Becoming a CTO Operator?

How Good Can Surgical Outcomes Be in Secondary MR? The Expert Surgeons Perspective

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content